Li, X., Jiang, P. & Fu, Cg. Preliminary comparative study on the effect of different chinese drugs for strengthening Pi (脾) in antagonizing diet induced obesity., Chin. J. Integr. Med. 16, 138–144 (2010). https://doi.org/10.1007/s11655-010-0138-4
Xiao Li, Ping Jiang, Chang-geng Fu. Preliminary comparative study on the effect of different chinese drugs for strengthening Pi (脾) in antagonizing diet induced obesity[J]. Chinese Journal of Integrative Medicine, 2010,16(2):138-144.
Li, X., Jiang, P. & Fu, Cg. Preliminary comparative study on the effect of different chinese drugs for strengthening Pi (脾) in antagonizing diet induced obesity., Chin. J. Integr. Med. 16, 138–144 (2010). https://doi.org/10.1007/s11655-010-0138-4DOI:
Xiao Li, Ping Jiang, Chang-geng Fu. Preliminary comparative study on the effect of different chinese drugs for strengthening Pi (脾) in antagonizing diet induced obesity[J]. Chinese Journal of Integrative Medicine, 2010,16(2):138-144. DOI: 10.1007/s11655-010-0138-4.
Preliminary comparative study on the effect of different chinese drugs for strengthening Pi (脾) in antagonizing diet induced obesity
摘要
To observe the difference in fatty degree
glucose-lipid disorder and adipose-hormones between diet induced obesity (DIO) rats and diet induced obesity resistance (DIO-R) rats
and to explore the effect and acting mechanism of Chinese drugs for strengthening Pi (脾
CD-SP) and those for both strengthening Pi and dissolving phlegm (CD-SPDP) in inhibiting obesity. Excepting eight rats allocated in the blank control group
the other 54 rats were fed with high-lipid forage for 12 weeks to establish models of obesity. Finally
30 DIO rats and 8 DIO-R rats (shown by their body weight) were obtained. The DIO rats were divided into three groups
which were given gastric perfusion
respectively
with normal saline (Group A)
CD-SP (Group B)
and CD-SPDP (Group C). Fourteen weeks later
the animals’ body weight (BW)
length (BL)
blood levels of fasting insulin (FIn)
fasting glucose (FBG)
triglyceride (TG)
cholesterol (TC)
leptin (LP)
neuropeptide Y (NPY)
C-reactive protein (CRP)
tumor necrosis factor-α(TNF-α)
adiponectin (AN)
and resistin (RS) were measured; insulin resistance index (IRI) was calculated
and the degree of obesity and lipid content in abdominal cavity of rats were estimated. Moreover
the levels of LP
CRP
TNF-α
AN and RS in homogenate of rats’ adipose tissues (ATH) were determined. After 12 weeks of high-lipid diet
the BW of DIO rats was higher than that of normal or DIO-R rats. After a 14-week continuous high-lipid diet feeding
in DIO rats
BW
lipid coefficient (LC)
and IRI were significantly increased (P<0.01); serum levels of TNF-α
LP and AN were lower
NPY was higher
while the ATH levels of LP and AN were lower and TNF-α was higher in DIO rats than in DIO-R rats (P<0.05 or P<0.01); blood levels of FBG and lipids in DIO rats showed an increasing trend but was statistically insignificant (P>0.05); no significant difference was found in serum levels of CRP and RS due to the overly high data dispersion. Comparisons of the 3 DIO groups showed that BW
body weight index (BWI)
LC and IRI were significantly lowered after treatment (P<0.01) in Group C
while these indexes were not significantly different between Group A and B; the serum levels of TNF-α
LP
and AN increased
NPY decreased in Group B and C
ATH levels of LP and AN increased
and TNF-α decreased in the two groups; but NPY
LP
and AN in blood and ATH were higher in Group C than those in Group B (P<0.05 or P<0.01). CD-SPDP could inhibit DIO and IR
showing that the effect is better than that of CD-SP
and its mechanism is related to promotion of LP and AN secretion and elevation of serum NPY.
Abstract
To observe the difference in fatty degree
glucose-lipid disorder and adipose-hormones between diet induced obesity (DIO) rats and diet induced obesity resistance (DIO-R) rats
and to explore the effect and acting mechanism of Chinese drugs for strengthening Pi (脾
CD-SP) and those for both strengthening Pi and dissolving phlegm (CD-SPDP) in inhibiting obesity. Excepting eight rats allocated in the blank control group
the other 54 rats were fed with high-lipid forage for 12 weeks to establish models of obesity. Finally
30 DIO rats and 8 DIO-R rats (shown by their body weight) were obtained. The DIO rats were divided into three groups
which were given gastric perfusion
respectively
with normal saline (Group A)
CD-SP (Group B)
and CD-SPDP (Group C). Fourteen weeks later
the animals’ body weight (BW)
length (BL)
blood levels of fasting insulin (FIn)
fasting glucose (FBG)
triglyceride (TG)
cholesterol (TC)
leptin (LP)
neuropeptide Y (NPY)
C-reactive protein (CRP)
tumor necrosis factor-α(TNF-α)
adiponectin (AN)
and resistin (RS) were measured; insulin resistance index (IRI) was calculated
and the degree of obesity and lipid content in abdominal cavity of rats were estimated. Moreover
the levels of LP
CRP
TNF-α
AN and RS in homogenate of rats’ adipose tissues (ATH) were determined. After 12 weeks of high-lipid diet
the BW of DIO rats was higher than that of normal or DIO-R rats. After a 14-week continuous high-lipid diet feeding
in DIO rats
BW
lipid coefficient (LC)
and IRI were significantly increased (P<0.01); serum levels of TNF-α
LP and AN were lower
NPY was higher
while the ATH levels of LP and AN were lower and TNF-α was higher in DIO rats than in DIO-R rats (P<0.05 or P<0.01); blood levels of FBG and lipids in DIO rats showed an increasing trend but was statistically insignificant (P>0.05); no significant difference was found in serum levels of CRP and RS due to the overly high data dispersion. Comparisons of the 3 DIO groups showed that BW
body weight index (BWI)
LC and IRI were significantly lowered after treatment (P<0.01) in Group C
while these indexes were not significantly different between Group A and B; the serum levels of TNF-α
LP
and AN increased
NPY decreased in Group B and C
ATH levels of LP and AN increased
and TNF-α decreased in the two groups; but NPY
LP
and AN in blood and ATH were higher in Group C than those in Group B (P<0.05 or P<0.01). CD-SPDP could inhibit DIO and IR
showing that the effect is better than that of CD-SP
and its mechanism is related to promotion of LP and AN secretion and elevation of serum NPY.
Levin BE, Joseph T, Susan Hogan. Metabolic features of diet-induced obesity without hyperphagia in yang rats. Am J Physiol 1986;251:Y433–440.
Levin BE, Triscari J, Hogan S, Sullivan AC. Resistance to diet-induced obesity: food intake, pancreatic sympathetic tone and insulin. Am J Physiol 1987;252:471–478.
Hota misligil GS. Molecular mechanisms of insulinresistance and the role of the adipocyte. Int Jobes Relat Metab Disord 2000;24:S23
Pan YH, Xue YM. Obesity and insulin resistance. Guangdong Med J (Chin) 2005;26:270–271.
Chen MD. Products of adipocytes and obesity/metabolic syndrome. Chin J Endocrinol Metabol (Chin) 2003;19:161–163.
Qian BC. The principle and method for preparing the obesity animal model. Chin Pharmacol Bull (Chin) 1993;9:752–776.
Li Y, Wang BZ, Qi CX, Jiao LB, Cao L, Shen XH. A new method of preparing the obesity rat model. J Hebei Med Univ (Chin) 2005;26:305–308.
Shi WY, Yao XJ, Dong DN, Liu L, Bai YL, Xu JF, et al. Study on levels of serum TNF-α in diet-induced obese rats. China Public Health (Chin) 2002;18:573–574.
Kraegen EW, Clark PW, Jenkins AB, Daley WA, Chisholm DJ, Storlien LH. Development of muscle insulin resistance after liver insulin resistance in high-fat-fed rats. Diabetes 1991;40:1397–1403.
Liang XZ, Zhang DF. Advances in research into relationship between adiponectin and coronary heart disease. Advances Cardiovasc Dis (Chin) 2007;28:940–944.
Cao L, Ma J. The Effect of Adiponectin in the Insulin Resistance. Forei Med Sci (Sec Hygiene, Chin) 2007;34:301–304.
Fang X, Sweeney G. Mechanisms regulating energy metabolism by adiponectin in obesity and diabetes. Biochem Soc Trans 2006;34:798–801.
Li JQ, Li PC. The adiponectin and the vasculitis disease. Advances Cardiovasc Dis (Chin) 2004;25:317–318.
Cheng H. Obesity, metabolism symptom and inflammation. Forei Med Sci (Sec Endoc) 2004,24:151–153.
Steppan CM, Bailey ST, Bhat S, Bhat S, Brown EJ, Banerjee RR, Wright CM, et al. The hormone resistin links obesity to diabetes. Nature 2001;409:307–312.
Yang G, Li L, Fang C, Zhang L, Li Q, Tang Y, et al. Effects of free fatty acids on plasma resistin and insulin resistance in awake rats. Metabolism 2005;54:1142–1146.
Kim KH, Lee K, Moon YS, Sul HS. A cysteine-rich adipose tissue-specific secretory factor inhibits adipocyte differentiation. J Biol Chem 2001;276:11252–11256.
Gu N, Guo XR, Chen RH. Resist in obesity and type 2 diabetes. Med Recapitul (Chin) 2006;12:159–161.
Nagaev l, Smith U. Insulin resistance and type 2 diabetes are not related to resistin expression in human fat cells or skeletal muscle. J Biochem Biophys Res Commun 2001;285:561–564.
Liu LM, Ye GS, Ye GJ. Experimental study of dietary obesity in rat induced by high fat diet. J Peking Univ (Health Sci, Chin) 1991;23:359–361.
Storlien LH, Jenkins AB, Chisholm DJ, Pascoe WS, Khouri S, Kraegen EW. Influence of dietary fat composition on development of insulin resistance in the rats. Diabetes1991;40:B280–289.
Xue CY, Zheng ZX, Zhang RX, Zhang XP, Li XY, Inoue SJ, et al. A study on mechanism of high fat and sucrose diets in obesity development in rats. Acta Nutrimenta Sin (Chin) 1998;21:B42–46.